Study finds new dual benefit mode of action for drug candidate to fight Covid

London, Jan 15 (IANS) A team of researchers has found a new dual attack mode of action while working on the development of a drug candidate against SARS-CoV-2 infections.According to the study, publi...

Become a proud member of 1947.com to access this content.